Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

NCT04681911 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Inetetamab
DRUG: Pyrotinib
DRUG: Capecitabine
DRUG: Gemcitabine
DRUG: Vinorelbine
DRUG: Carboplatin
DRUG: Albumin paclitaxel
DRUG: Eribulin

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University